share_log

Truist Securities Reiterates Buy on Incyte, Lowers Price Target to $83

Benzinga ·  May 1 08:47

Truist Securities analyst Srikripa Devarakonda reiterates Incyte (NASDAQ:INCY) with a Buy and lowers the price target from $84 to $83.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment